Multimodality imaging, including echocardiography as the first-line method and cardiac MRI for tissue characterization, is essential for diagnosing and identifying different phenotypes of HFpEF.
Multimodality imaging, particularly echocardiography and cardiac MRI, plays a crucial role in the diagnosis, phenotyping, and prognostic evaluation of patients with HFpEF.
Heart failure with preserved ejection fraction (HFpEF) is an important global health problem. Despite increased prevalence due to improved diagnostic options, limited improvement has been achieved in cardiac outcomes. HFpEF is an extremely complex syndrome and multimodality imaging is important for diagnosis, identifying its different phenotypes and determining prognosis. Evaluation of left ventricular filling pressures using echocardiographic diastolic function parameters is the first step of imaging in clinical practice. The role of echocardiography is becoming more popular and with the recent developments in deformation imaging, cardiac MRI is extremely important as it can provide tissue characterisation, identify fibrosis and optimal volume measurements of cardiac chambers. Nuclear imaging methods can also be used in the diagnosis of specific diseases, such as cardiac amyloidosis.
Ünlü et al. (Tue,) conducted a review in Heart failure with preserved ejection fraction (HFpEF). Multimodality imaging was evaluated. Multimodality imaging, including echocardiography as the first-line method and cardiac MRI for tissue characterization, is essential for diagnosing and identifying different phenotypes of HFpEF.